Delving into the Latest Updates on New Approaches to Neuroblastoma Therapy with Synapse

概览

疾病领域	数量

肿瘤	1

排名前五的药物类型	数量

自然杀伤细胞疗法	1

关联

1

项与 New Approaches to Neuroblastoma Therapy 相关的药物

Expanded NK Cells(New Approaches to Neuroblastoma Therapy)

靶点-

作用机制

自然杀伤细胞替代物

在研机构

New Approaches to Neuroblastoma Therapy

原研机构

New Approaches to Neuroblastoma Therapy

在研适应症

难治性神经母细胞瘤

非在研适应症-

最高研发阶段临床1期

首次获批国家/地区-

首次获批日期-

1

项与 New Approaches to Neuroblastoma Therapy 相关的临床试验

NCT02573896

/ Active, not recruiting临床1期

A Phase I Dose Escalation Study of Autologous Expanded Natural Killer (NK) Cells for Immunotherapy of Relapsed Refractory Neuroblastoma With Dinutuximab +/- Lenalidomide

This NANT trial will determine the maximum tolerated dose (MTD) of autologous expanded natural killer (NK) cells when combined with standard dosing of dinutuximab and will assess the feasibility of adding lenalidomide at the recommended Phase II dose of the expanded NK cells with dinutuximab, for treatment of children with refractory or recurrent neuroblastoma.

开始日期2019-01-14

申办/合作机构

New Approaches to Neuroblastoma Therapy

[+2]

100 项与 New Approaches to Neuroblastoma Therapy 相关的临床结果

登录后查看更多信息

0 项与 New Approaches to Neuroblastoma Therapy 相关的专利（医药）

登录后查看更多信息

100 项与 New Approaches to Neuroblastoma Therapy 相关的药物交易

登录后查看更多信息

100 项与 New Approaches to Neuroblastoma Therapy 相关的转化医学

登录后查看更多信息